Global Supercapacitor Technologies and Markets, 2026
Sep 18, 2017 11:23 am UTC| Business
Dublin, Sept. 18, 2017 -- The "Supercapacitor Technologies and Markets 2016-2026" report has been added to Research and Markets' offering. The report estimates that the high-power energy storage...
Daseke, Inc. Announces Public Offering of Common Stock
Sep 18, 2017 11:14 am UTC| Business
ADDISON, Texas, Sept. 18, 2017 -- Daseke, Inc. (NASDAQ:DSKE) (“Daseke” or the “Company”) today announced the commencement of an underwritten public offering of 4,000,167 shares of its common stock by the Company and...
Masergy Continues to Demonstrate Cyber Security Expertise With PCI Vendor Compliance Certification
Sep 18, 2017 11:01 am UTC| Business
DALLAS, Sept. 18, 2017 -- Masergy, a leading provider of hybrid networking, managed security and cloud communications solutions, today announced its PCI Compliance Professional Services certification. Masergy has...
Sep 18, 2017 11:01 am UTC| Business
PRESS RELEASE Immunocore and the Bill Melinda Gates Foundation Collaborate to Develop Immunotherapies for Infectious Diseases $40 million investment to accelerate development of Immunocore's ImmTAV® and...
Arix Bioscience plc notes positive clinical study announcements from Autolus Limited
Sep 18, 2017 11:01 am UTC| Business
Arix Bioscience plc notes positive clinical study announcements from Autolus Limited LONDON, 18 September 2017: Arix Bioscience plc (LSE: ARIX) ("Arix Bioscience"), a global healthcare and life science company...
Sep 18, 2017 11:00 am UTC| Business
Pluristem’s Ongoing Phase III CLI trial has been selected for accelerated approval pathways in both the U.S. and EuropeFast Track Designation allows for expedited review of drugs to treat serious conditions with unmet...
RedHill Biopharma to Present at the Cantor Fitzgerald Global Healthcare Conference
Sep 18, 2017 11:00 am UTC| Business
TEL-AVIV, Israel and RALEIGH, N.C., Sept. 18, 2017 -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on late...